Can You Take Codeine with Doxepin?
A plain-English look at the moderate interaction between Codeine (Aspen Pharmacare Australia Pty Ltd) and Doxepin (DEPTRAN 50 doxepin 50mg (as hydrochloride) tablet blister pack) — what it means, why it happens, and what to talk to your doctor or pharmacist about.
Combining Codeine (Aspen Pharmacare Australia Pty Ltd) with Doxepin (DEPTRAN 50 doxepin 50mg (as hydrochloride) tablet blister pack) is a moderate interaction requiring caution and monitoring. Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
Not sure about your specific combination? Check it in the Drug Interaction Checker →
Key Takeaways
- Interaction severity: Moderate
- Risk: Serotonin syndrome (agitation, hyperthermia, rigidity), excessive sedation.
- Mechanism: Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
- Codeine: S8 in Australia, moderate risk
- Doxepin: S4 in Australia, moderate risk
- Claims action: Monitor and document. Request clinical justification if combination is ongoing.
Codeine vs Doxepin at a Glance
| Property | Codeine | Doxepin |
|---|---|---|
| Brand names | Aspen Pharmacare Australia Pty Ltd | DEPTRAN 50 doxepin 50mg (as hydrochloride) tablet blister pack, DEPTRAN 75 doxepin 75mg (as hydrochloride) tablet blister pack, DEPTRAN 25 doxepin 25mg (as hydrochloride) capsule blister pack |
| Drug class | opioid | antidepressant |
| Risk level | moderate | moderate |
| TGA Schedule (AU) | S8 | S4 |
Why Is This Combination Dangerous?
Risk of serotonin syndrome, especially with tramadol and tapentadol combined with SSRIs/SNRIs. Additive CNS depression with sedating antidepressants.
Regulatory Guidance by Jurisdiction
Australia TGA / SIRA / WorkSafe
The TGA and Australian Medicines Handbook classify this as a moderate drug interaction requiring monitoring and clinical review.
United Kingdom NICE / MHRA / FPM
NICE guidelines advise against combining multiple serotonergic medications due to the risk of serotonin syndrome. For personal injury claims, antidepressant prescribing should be reviewed for injury relatedness and appropriateness.
United States FDA / CDC / State WC
The FDA has issued Drug Safety Communications about the risk of serotonin syndrome with concurrent use of serotonergic medications. Workers compensation nurse case managers should flag this combination for prescriber review.
What Claims Professionals Should Do
- Document the combination in the claim file with a note on interaction risk
- Request clinical justification from the prescriber at the next review
- Monitor for adverse effects including excessive sedation, falls, and cognitive impairment
- Assess injury relatedness of both medications to the compensable condition
- Review at next claim assessment and consider whether the combination is still clinically appropriate
Check this medication against your full medication list
Check all interactions for Codeine and Doxepin across your claimant's full medication list.
Allmeds AI Pharmacist scans interactions, schedules, and risk flags across your entire medication profile in minutes. Free for individuals; team plans for case managers, insurers, and schemes.
Related Resources
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.